Zobrazeno 1 - 10
of 122
pro vyhledávání: '"S. Rietbrock"'
Autor:
P.-G. Merz, S. Rietbrock, C. Gorkow, C. Sieder, J. S. E. Dericks-Tan, A. Schrödter, H. D. Taubert, D. Loew
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 104:447-453
The effects of three doses of a special Agnus castus extract (BP1095E1) - extracts from 120 mg, 240 mg and 480 mg of drug per day - were examined within the framework of a placebo-controlled clinical study of tolerance and prolactin secretion in 20 h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ff65d43e487a189cd5d2f2304a5dc92
https://doi.org/10.1055/s-0029-1211483
https://doi.org/10.1055/s-0029-1211483
Autor:
Ulrich Jaehde, Matthias Schwab, Andreas Josting, Alexander Jetter, Stefan Wilde, Dagmar Busse, Beate Klimm, Georg Hempel, Dirk Kasel, S. Rietbrock, Andreas Engert, Uwe Fuhr, S. Reif, U. Merkel, Volker Diehl
Publikováno v:
Clinical Pharmacokinetics. 46:319-333
The BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone) chemotherapy regimen for the treatment of advanced Hodgkin’s lymphoma has a superior outcome, but its toxicity (mainly haematotoxicity) is p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51ba5691fbfefb9ae2acde014f1ce4bb
https://doi.org/10.2165/00003088-200746040-00005
https://doi.org/10.2165/00003088-200746040-00005
Publikováno v:
British Journal of Anaesthesia. 84:443-449
The pharmacokinetic characteristics of desflurane, isoflurane and sevoflurane (16 patients for each anaesthetic) were estimated from measurements of inspired and end-expired agent concentrations and ventilation, obtained during routine anaesthesia in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3c13dc6b2901db8efbe4754f006c33f
https://doi.org/10.1093/oxfordjournals.bja.a013467
https://doi.org/10.1093/oxfordjournals.bja.a013467
Publikováno v:
Clinical Pharmacokinetics. 29:243-256
Studies on the concentration-effect relationship of levodopa in Parkinson's disease have established that: (1) in patients with a fluctuating response to levodopa, concentration-effect profiles are steeper and markedly shifted to the right (i.e. pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d74a327559977660106f08e676786135
https://doi.org/10.2165/00003088-199529040-00004
https://doi.org/10.2165/00003088-199529040-00004
Autor:
Matthias Schwab, S. Wilde, M Zaigler, Volker Diehl, S. Rietbrock, Ulrich Jaehde, M. Sieber, S. Reif, Georg Hempel, Alexander Jetter, H. Tesch, Uwe Fuhr, Dagmar Busse, H. Menzel
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 40:586-588
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e55a60d043aa3f192998480311ef5df
https://doi.org/10.5414/cpp40586
https://doi.org/10.5414/cpp40586
Publikováno v:
European Journal of Clinical Pharmacology. 43:273-276
A novel slow release preparation containing 24 mg molsidomine has been investigated in 6 healthy subjects. Individual concentration/time-profiles after the tablet showed two separate concentration peaks at 2.2 h and 15.0 h. The relative bioavailabili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f508d96ab80b211c8444e81cc389798a
https://doi.org/10.1007/bf02333022
https://doi.org/10.1007/bf02333022
Publikováno v:
Journal of internal medicine. 264(5)
To investigate the risk of myocardial infarction (MI) with diclofenac, ibuprofen and naproxen, taking into account the exposure patterns.Retrospective cohort study using the General Practice Research Database. Setting. UK primary care. Subjects. Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::339a64ec7530ab5f6a9659f12afb6ec7
https://pubmed.ncbi.nlm.nih.gov/18624902
https://pubmed.ncbi.nlm.nih.gov/18624902
Publikováno v:
International journal of clinical pharmacology and therapeutics. 42(2)
Objective: Disorders of steroid hormone metabolism might be related to the etiology of focal nodular hyperplasia of the liver (FNH), a benign tumor, especially prevalent in women. The cytochrome P450 1AI (CYP1A1) enzyme is implicated in the bioactiva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::446ae93b0b472fbc66f00bb1eb9abcdd
https://pubmed.ncbi.nlm.nih.gov/15180167
https://pubmed.ncbi.nlm.nih.gov/15180167
Autor:
S. Rietbrock, M. Weiss
Publikováno v:
Klinische Pharmakologie ISBN: 9783642633201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9a37a4d24f3d6eecf4d4b5148a836ad
https://doi.org/10.1007/978-3-642-57636-2_4
https://doi.org/10.1007/978-3-642-57636-2_4
Autor:
S Beckmann-Knopp, R Weyhenmeyer, S Rietbrock, W Lang, K T Beckurts, R. Böcker, M Hunz, Uwe Fuhr
Publikováno v:
Pharmacologytoxicology. 86(6)
Silibinin, the main constituent of silymarin, a flavonoid drug from silybum marianum used in liver disease, was tested for inhibition of human cytochrome P-450 enzymes. Metabolic activities were determined in liver microsomes from two donors using se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87b1d6a5322045448fb06e77555fb406
https://pubmed.ncbi.nlm.nih.gov/10895987
https://pubmed.ncbi.nlm.nih.gov/10895987